大腸癌治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Colorectal Cancer Drugs Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Disease Overview
06.1 Understanding the Disease
06.2 Pathophysiology
06.3 Epidemiology
06.4 Diagnosis
06.5 Staging
06.5.1 Staging: Colon Cancer
06.5.2 Staging: Rectal Cancer
06.6 Management
06.7 Economic Burden

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.2.1 Colorectal Cancer Drugs Market in US
07.2.2 Colorectal Cancer Drugs Market in Germany
07.2.3 Colorectal Cancer Drugs Market in Spain
07.2.4 Colorectal Cancer Drugs Market in Japan
07.2.5 Colorectal Cancer Drugs Market in China
07.3 Five Forces Analysis

08.Market Segmentation by Type of Molecules
08.1 Small molecules
08.2 Biologics

09.Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral

10.Geographical Segmentation
10.1 Colorectal Cancer Drugs Market in Americas
10.1.1 Market Size and Forecast
10.2 Colorectal Cancer Drugs Market in EMEA
10.2.1 Market Size and Forecast
10.3 Colorectal Cancer Drugs Market in APAC
10.3.1 Market Size and Forecast

11.Key Leading Countries
11.1 US
11.2 Japan
11.3 Germany
11.4 Spain
11.5 China

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Competitive Assessment of Top Drugs for Colorectal Cancer
19.2.2 F. Hoffmann-La Roche
19.2.3 Merck Serono
19.2.4 Bristol-Myers Squibb
19.2.5 Amgen
19.2.6 Sanofi
19.2.7 Bayer
19.3 Other and Future Prominent Vendors

20.Key Takeaways

21.Key Vendor Analysis
21.1 Amgen
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Product Portfolio by Revenue 2013
21.1.5 Business Segmentation by Revenue 2012 and 2013
21.1.6 Geographical Segmentation by Revenue 2013
21.1.7 Business Strategy
21.1.8 Recent Developments
21.1.9 SWOT Analysis
21.2 Bayer
21.2.1 Key facts
21.2.2 Business overview
21.2.3 Business segmentation by revenue 2014
21.2.4 Business segmentation by revenue 2013 and 2014
21.2.5 Geographical segmentation by revenue 2014
21.2.6 Business strategy
21.2.7 Recent developments
21.2.8 SWOT analysis
21.3 Bristol-Myers Squibb Co.
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Key Product Offerings
21.3.4 Revenue by Geography
21.3.5 Business Strategy
21.3.6 Key Information
21.3.7 SWOT Analysis
21.4 F. Hoffmann-La Roche Ltd.
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Sales by Geography
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
21.5 Merck Serono
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Geographical Segmentation by Revenue 2013
21.5.4 Business Strategy
21.5.5 Recent Developments
21.5.6 SWOT Analysis
21.6 Sanofi SA
21.6.1 Key Facts
21.6.2 Business Description
21.6.3 Business Segmentation
21.6.4 Revenue by Business Segmentation
21.6.5 Revenue Comparison 2012 and 2013
21.6.6 Sales by Geography
21.6.7 Business Strategy
21.6.8 Key Developments
21.6.9 SWOT Analysis

22.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Drivers and Challenges of the Global Colorectal Cancer Drugs Market
Exhibit 3: Diagnosis of Colorectal Cancer
Exhibit 4: Management of Colorectal Cancer
Exhibit 5: A Snapshot of the Economic Burden of the Global Colorectal Cancer Drugs Market
Exhibit 6: Snapshot of the Global Colorectal Cancer Drugs Market
Exhibit 7: Global Colorectal Cancer Drugs Market 2014-2019 ($ millions)
Exhibit 8: Colorectal Cancer Drugs Market in US 2014-2019 ($ millions)
Exhibit 9: Colorectal Cancer Drugs Market in Germany 2014-2019 ($ millions)
Exhibit 10: Colorectal Cancer Drugs Market in Spain 2014-2019 ($ millions)
Exhibit 11: Colorectal Cancer Drugs Market in Japan 2014-2019 ($ millions)
Exhibit 12: Colorectal Cancer Drugs Market in China 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global Colorectal Cancer Drugs Market by Type of Molecules
Exhibit 14: Segmentation of Global Colorectal Cancer Drugs Market by Type of Molecules, 2014
Exhibit 15: Segmentation of Global Colorectal Cancer Drugs Market by Route of Administration
Exhibit 16: Segmentation of Global Colorectal Cancer Drugs Market by Route of Administration, 2014
Exhibit 17: Global Colorectal Cancer Drugs Market by Geographical Segmentation 2014
Exhibit 18: Colorectal Cancer Drugs Market in Americas 2014-2019 ($ millions)
Exhibit 19: Colorectal Cancer Drugs Market in EMEA 2014-2019 ($ millions)
Exhibit 20: Colorectal Cancer Drugs Market in APAC 2014-2019 ($ millions)
Exhibit 21:
Exhibit 22: Drivers of the Global Colorectal Cancer Drugs Market
Exhibit 23: Challenges of the Global Colorectal Cancer Drugs Market
Exhibit 24: Trends of the Global Colorectal Cancer Drugs Market
Exhibit 25: YoY Growth Rate of the Major Colorectal Cancer Drugs 2010-2014 ($ millions)
Exhibit 26: F. Hoffmann-La Roche: Product Portfolio
Exhibit 27: Avastin: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 28: Avastin: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 29: YoY Revenues and Growth Rate of Avastin in the US 2010-2014 ($ millions)
Exhibit 30: YoY Revenues and Growth Rate of Avastin in Europe 2010-2014 ($ millions)
Exhibit 31: YoY Revenues and Growth Rate of Avastin in Japan 2010-2014 ($ millions)
Exhibit 32: YoY International Revenues and Growth Rate of Avastin 2010-2014 (Except US, Europe, Japan) ($ millions)
Exhibit 33: Xeloda: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 34: Xeloda: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 35: YoY Revenues and Growth Rate of Xeloda in the US ($ millions)
Exhibit 36: YoY Revenues and Growth Rate of Xeloda in Europe 2010-2014 ($ millions)
Exhibit 37: YoY Revenues and Growth Rate of Xeloda in Japan 2010-2014 ($ millions)
Exhibit 38: YoY International Revenues and Growth Rate of Xeloda (Except US, Europe, Japan) ($ millions)
Exhibit 39: Merck Serono: Product Portfolio
Exhibit 40: Erbitux: Revenue and YoY Growth Rate except US and Canada 2010-2014 ($ millions)
Exhibit 41: Erbitux: Region-wise Revenues 2012-2014 ($ millions)
Exhibit 42: Erbitux: Revenue and YoY Growth Rate in Europe 2012-2014 ($ millions)
Exhibit 43: Erbitux: Revenue and YoY Growth Rate in Emerging Markets 2012-2014 ($ millions)
Exhibit 44: Erbitux: Revenue and YoY Growth Rate in ROW 2012-2014 ($ millions)
Exhibit 45: Bristol-Myers Squibb: Product Portfolio
Exhibit 46: Erbitux: Revenue and YoY Growth Rate in US and Canada 2010-2014 ($ millions)
Exhibit 47: Amgen: Product Portfolio
Exhibit 50: Vectibix: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 51: Vectibix: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 52: Sanofi: Product Portfolio
Exhibit 53: Eloxatin: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 54: Eloxatin: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 55: YoY Revenues and Growth Rate of Eloxatin in the US ($ millions)
Exhibit 56: YoY Revenues and Growth Rate of Eloxatin in Europe ($ millions)
Exhibit 57: YoY Revenues and Growth Rate of Eloxatin in Emerging Markets ($ millions)
Exhibit 58: YoY Revenues and Growth Rate of Eloxatin in ROW 2010-2014 ($ millions)
Exhibit 59: Zaltrap: Global Revenue and YoY Growth Rate 2012-2014 ($ millions)
Exhibit 60: Zaltrap: Region-wise Revenue 2013-2014 ($ millions)
Exhibit 61: Bayer: Product Portfolio
Exhibit 62: Stivarga: Global Revenue and YoY Growth Rate 2012-2014 ($ millions)
Exhibit 63: Key Takeaways: Global Colorectal Cancer Drugs Market 2015-2019
Exhibit 64: Amgen: Business Segmentation by Revenue 2013
Exhibit 65: Amgen: Product Portfolio by Revenue 2013
Exhibit 66: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 67: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 68: Bayer: Business segmentation by revenue 2014
Exhibit 69: Bayer: Business segmentation by revenue 2013 and 2014 (US$ billion)
Exhibit 70: Bayer: Geographical segmentation by revenue 2014
Exhibit 71: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 72: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 73: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 74: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 75: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 76: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 77: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 78: Sanofi SA: Business Segmentation
Exhibit 79: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 80: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 81: Sanofi SA: Sales Revenue by Geographical Segmentation 2013


【レポート販売概要】

■ タイトル:大腸癌治療薬の世界市場2015-2019
■ 英文:Global Colorectal Cancer Drugs Market 2015-2019
■ 発行日:2015年6月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6118
■ 調査対象地域:グローバル
  • テレコム(通信)業界におけるマネージドサービス市場(2014-2019)
    Telecom operators are under persistent pressure to manage capital expenditures related with network deployment and to reduce network operating costs. Managed services providers help network operators realize those goals. The next stage in evolution is to outsource value-added services including content, commerce, and next generation communication services. This is a key development as network oper …
  • 3D度量衡学の世界市場:CMM(座標測定機)、VMM(ビデオ測定機)、ODS(光デジタイザ&スキャナ)
    The 3D metrology market is expected to reach USD 10.90 Billion by 2022, at a CAGR of 7.0% between 2016 and 2022. The major factors driving the market are highly accurate inspection owing to three-dimensional data for modeling and analysis, increasing focus on quality control, and limitations of traditional measurement devices to address manufacturing issues. The market for the architecture and con …
  • 構造的心疾患治療器具の世界市場2018-2022
    About Structural Heart Disease Treatment Devices Global structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart. Technavio’s analysts forecast the Global Structural Heart Disease Treatment Devices Market to grow at a CAGR of …
  • 債務担保証券(CDO)の世界市場2016-2020
    About the Collateralized Debt Obligation (CDO) Market CDO refer to the securities that are packaged as one unit and serves as collateral for investors. The packaged assets comprise the corporate debt, mortgages, credit card, or automotive loans that are otherwise individual fixed income assets, which are sold on the secondary market. CDO allows banks and large corporations to sell off their debt, …
  • 体外診断(IVD)の世界市場予測(~2021):製品別、技術別(イムノアッセイ、臨床化学、分子診断、血液学)、用途別
    The global in vitro diagnostics market is estimated to reach USD 78.74 Billion by 2021, at a CAGR of 5.5% during the forecast period. The growing acceptance of molecular diagnostics for personalized medicine, increase in prevalence of chronic lifestyle diseases, and rise in demand for point-of-care testing are driving market growth. New range of condition-specific markers and tests with advances i …
  • 栄養補助食品の世界市場予測(~2025年)
    “Increasing awareness about the benefits of nutritional-rich products is projected to drive the growth of the nutraceutical products market.”The global nutraceutical products market size is projected to grow from USD 267.4 billion in 2019 to USD 404.8 billion by 2025, recording a CAGR of 7.2% during the forecast period. The growth in the aging population and the rising number of chronic diseases a …
  • ヘッドライト制御モジュールの世界市場予測(~2027年)
    “Rising disposable income and increasing sales of premium vehicles and SUVs to drive the growth of the headlight control module market.” The headlight control module market is projected to grow from USD 3.6 billion in 2019 to USD 5.0 billion in 2027 at a CAGR of 4.3% during the forecast period. Headlight control modules are installed typically in premium vehicles and SUVs as a superior feature. Th …
  • Whiting Petroleum Corporation社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Whiting Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Whiting Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
  • 自動車トルクベクタリング装置の世界市場2017-2021
    About Automotive Torque Vectoring SystemTorque vectoring as a technology is developed as an addition to the basic or standard differential. Hence, this technology performs the basic tasks of a usual differential, as well as transmitting torque independently to the driving wheels. This ability to transfer independent torque generally results in the improvement of vehicular handling and traction. To …
  • 医療用使い捨て手袋の世界市場2015-2019
    About Medical Disposable Gloves Medical disposable gloves are used in performing medical procedures and examinations to help prevent possible contamination between healthcare personnel and patients. The gloves are made from different polymers, such as neoprene, latex, vinyl and nitrile rubber, and available in both powdered and powder-free forms. Cornstarch is usually used to lubricate the powdere …
  • 世界における注射器及び注射針の製品パイプライン動向2015
    Syringes and Needles - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Syringes and Needles - Pipeline Review, 2015" provides an overview of Syringes and Needles currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players in …
  • 結晶セルロース(MCC)の世界市場動向及び予測
    Microcrystalline cellulose (MCC) is used as binder, thickening agent, suspension agent, and bulking agent in a variety of application such as food & beverages, pharmaceutical, cosmetics & personal care, and others. This report on the global MCC market covers all major regions such as Asia-Pacific, Europe, North America, and Rest of the World. The report analyzes the market trends and provides fore …
  • UCaaSの世界市場2015-2019
    About Global Unified Communication as a Service Market UCaaS refers to integration of real-time business communication services such as voice messaging, video conferencing, text messages, and other mobility features delivered through cloud. Over the years, businesses worldwide are witnessing unprecedented dependence on various advanced technologies and adopting various integration solutions to run …
  • 世界のデジタル放送と映画撮影カメラ市場動向(2014~2018)
    TechNavio's analysts forecast the Global Digital Broadcast and Cinematography Cameras market to grow at a CAGR of 1.51 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing use of 2k and 4k cameras in digital movies. The Global Digital Broadcast and Cinematography Cameras market has also been witnessing the increasing demand for cameras from …
  • 自動車用電動油圧式パワーステアリングシステムの世界市場2019-2023
    108 pages, November 2018 About this market The development of steer-by-wire systems is expected to drive growth in the market. Steer-by-wire is the most advanced steering system that uses a series of sensors to monitor steering inputs of the driver and transmits the information electronically to the vehicle’s steering gears. Technavio’s analysts have predicted that the automotive electro-hydraulic …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。